Format

Send to

Choose Destination
Head Neck. 2003 Sep;25(9):732-40.

Betulinic acid: a new cytotoxic compound against malignant head and neck cancer cells.

Author information

1
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. dietmar.thrunher@univie.ac.at

Abstract

BACKGROUND:

A new compound, betulinic acid, has been found to be cytotoxic against a variety of tumor cells originating from the neural crest. Its efficacy against head and neck squamous cellular carcinoma cell lines has so far not been tested.

METHODS:

Cell numbers were assayed by automated counting; caspase activation and programmed cell death were determined using an antibody specific for an apoptosis-associated epitope in epithelial cells. The expression pattern of Bcl-2 family members was assessed by Western blotting.

RESULTS:

In two HNSCC cell lines betulinic acid induced apoptosis, which was characterized by a dose-dependent reduction in cell numbers, emergence of apoptotic cells, and an increase in caspase activity. Western blot analysis of the expression of various Bcl-2 family members in betulinic acid-treated cells showed, surprisingly, a suppression of the expression of the proapoptotic protein Bax but no changes in Mcl-1 or Bcl-2 expression.

CONCLUSION:

These data clearly demonstrate for the first time that betulinic acid has apoptotic activity against HNSCC cells.

PMID:
12953308
DOI:
10.1002/hed.10231
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center